Rajarshi Pal is currently working as an Assistant Professor and Principal Investigator of the Embryonic Stem Cell Biology Group at Manipal Institute of Regenerative Medicine, Bangalore, Constituent Institute of the Manipal University, India. In January 2011, Pal made an important transition to the academia after successful accomplishment of an 8-year-long stint in the burgeoning stem cell industry. During this period, Pal served different R&D roles at Reliance Life Sciences, Mumbai; Stempeutics Research Pvt. Ltd., Bangalore, and Stempeutics Research Malaysia, Kuala Lumpur. Pal has been instrumental in designing stem-cell-based assays and lead drug discovery programs employing novel cell culture systems. Pal has also contributed to stem-cell-based product development for human embryonic stem cell derivation, characterization and adult stem cell expansion, and differentiation under conditions for basic research and regenerative medicine. Pal’s recently completed Doctoral dissertation emphasizes on modeling pluripotent stem cells to study reproductive and developmental toxicity in vitro. Pal took keen interest and played a pivotal role in jointly organizing several stem cell workshops and symposia nationally and internationally. Likewise, he has received training in genetic manipulation of embryonic stem cells from the Centre for Stem Cell Biology, University of Sheffield, UK. After completing his graduate and postgraduate studies at the prestigious Presidency University, Kolkata, India; Pal joined the National Institute of Immunology, Department of Biotechnology, Government of India, New Delhi, Delhi, India, to study the effects of environmental toxicants on germ cell death from 2001 to 2003. Pal authored over 25 publications in indexed international peer-reviewed journals. He has 4 patents (including 2 US patents) to his credit and has contributed to 4 book chapters on various aspects of stem cell biology published by Nova, McGraw-Hill, and Wiley-Blackwell Publishers.
Biography Updated on 29 May 2012